Tisdale M, Ertl P, Larder B A, Purifoy D J, Darby G, Powell K L
Wellcome Research Laboratories, Beckenham, Kent, United Kingdom.
J Virol. 1988 Oct;62(10):3662-7. doi: 10.1128/JVI.62.10.3662-3667.1988.
We describe the production of eight monoclonal antibodies reactive with human immunodeficiency virus type 1 reverse transcriptase (RT) by immunization of mice with purified recombinant RT. These antibodies were found to react with one or the other of two regions of the enzyme and were found to be useful in immunodeficiency purification of large amounts of the enzyme. One epitope located at the C terminus of the enzyme was of particular interest, since it was present in only the larger, 66-kilodalton (kDa) RT species and not its smaller, 51-kDa counterpart. To define this epitope, a series of mutants was made which synthesized C-terminally truncated RT. These mutants indicated that the same region of the enzyme, when deleted, both removed the C-terminal epitope and drastically reduced RT activity, indicating the importance of this region in the function of the enzyme; however, even the 51-kDa enzyme component had demonstrable activity.
我们描述了通过用纯化的重组人免疫缺陷病毒1型逆转录酶(RT)免疫小鼠来产生8种与该酶反应的单克隆抗体。发现这些抗体与该酶的两个区域中的一个或另一个发生反应,并发现它们可用于大量该酶的免疫纯化。位于该酶C末端的一个表位特别令人感兴趣,因为它仅存在于较大的66千道尔顿(kDa)RT物种中,而不存在于较小的51-kDa对应物中。为了确定这个表位,制备了一系列合成C末端截短RT的突变体。这些突变体表明,该酶的同一区域在缺失时,既去除了C末端表位,又大幅降低了RT活性,表明该区域在酶功能中的重要性;然而,即使是51-kDa的酶组分也具有可证明的活性。